6THX image
Entry Detail
PDB ID:
6THX
Title:
IRAK4 in complex with inhibitor
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2019-11-21
Release Date:
2020-10-28
Method Details:
Experimental Method:
Resolution:
1.99 Å
R-Value Free:
0.25
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
I 2 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Interleukin-1 receptor-associated kinase 4
Chain IDs:A, B
Chain Length:308
Number of Molecules:2
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
SEP A SER modified residue
TPO A THR modified residue
Ligand Molecules
Primary Citation
Improving metabolic stability and removing aldehyde oxidase liability in a 5-azaquinazoline series of IRAK4 inhibitors.
Bioorg.Med.Chem. 28 115815 115815 (2020)
PMID: 33091850 DOI: 10.1016/j.bmc.2020.115815

Abstact

In this article, we report our efforts towards improving in vitro human clearance in a series of 5-azaquinazolines through a series of C4 truncations and C2 expansions. Extensive DMPK studies enabled us to tackle high Aldehyde Oxidase (AO) metabolism and unexpected discrepancies in human hepatocyte and liver microsomal intrinsic clearance. Our efforts culminated with the discovery of 5-azaquinazoline 35, which also displayed exquisite selectivity for IRAK4, and showed synergistic in vitro activity against MyD88/CD79 double mutant ABC-DLBCL in combination with the covalent BTK inhibitor acalabrutinib.

Legend

Protein

Chemical

Disease

Primary Citation of related structures